Does DENOSUMAB Cause Therapeutic product effect delayed? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic product effect delayed have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.
5
Reports of Therapeutic product effect delayed with DENOSUMAB
0.0%
of all DENOSUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From DENOSUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
DUPILUMAB (90)
IBUPROFEN (88)
DICLOFENAC (85)
Which DENOSUMAB Alternatives Have Lower Therapeutic product effect delayed Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE